Home
Company
Our Lead Product
Pipeline
News-Media
Contact Us

Home
Company
Our Lead Product
Pipeline
News-Media
Contact Us

Augxano and BIT Pharma enter into an Agreement for Commercialization Support in Asia

Startseite » News » Augxano and BIT Pharma enter into an Agreement for Commercialization Support in Asia

< News Overview
Print
Email

14. December 2022

Augxano and BIT Pharma enter into an Agreement for Commercialization Support in Asia

LEAD PRODUCT

BIT PHARMA

Company
Lead Product
Pipeline
Team and Management
Scientific Literature
News-Media
Contact

LEGAL

Privacy Policy
Copyright

Funded by seed financing of the BMWFW, processed by Austria Wirtschafts Service.

© 2016 BIT Pharma. All Rights Reserved.

Contact Us

Send us an email for further inquiry.

Not readable? Change text.

ASPEN And BIT PHARMA Enter Into An Exclusive Agreement For A Nicardipine-Based Intracerebral ImplantCompany

Phase 2 data with NicaPlant ® in aneurysmal subarachnoid haemorrhage patients will be presented at the XXVI Congress of Spanish Society of Neurosurgery (SENEC)Pipeline